Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
about
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastomaLack of correlation between MYCN expression and the Warburg effect in neuroblastoma cell lines.Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.Clinical experience with (18)F-fluorodeoxyglucose positron emission tomography and (123)I-metaiodobenzylguanine scintigraphy in pediatric neuroblastoma: complementary roles in follow-up of patients2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.Silencing of doublecortin-like (DCL) results in decreased mitochondrial activity and delayed neuroblastoma tumor growth.Role of positron emission tomography-computed tomography in staging and early chemotherapy response evaluation in children with neuroblastomaPositron emission tomography in cancer research and treatment.Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma.Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: a case reportPET-CT in children: where is it appropriate?New frontiers in pediatric oncologic imagingSensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma.Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.Molecular imaging of adrenal neoplasms.Nuclear medicine and multimodality imaging of pediatric neuroblastoma.A comprehensive characterization of rare mitochondrial DNA variants in neuroblastoma.Paediatric nuclear medicine imaging.Comparison of diagnosing and staging accuracy of PET (CT) and MIBG on patients with neuroblastoma: Systemic review and meta-analysis.Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma.Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
P2860
Q24186888-2CC94FFD-51F7-4A02-A181-C62EA233CBBCQ33369231-33487E91-BE7D-4F80-AC75-F1403AD5153EQ33834340-62C1DF15-3286-4F7B-9C92-FB553AA8CDB2Q33969446-67C8C8B4-B628-4FEF-8175-EBAE31645AF3Q34404416-849CC60D-B5F6-4055-8E0D-49C4A544A13FQ35005945-BF38D81E-6CAC-4C24-8969-FDA77FC63813Q35030243-161FE183-DA29-4DA5-853B-202880846F64Q35081118-14EF11E0-CAB5-4995-8438-FD87AFAE31DEQ35238424-45C0B647-2B03-489A-904C-3F859E9A947AQ35764141-EFA3DF49-D59A-4E0B-81CA-FBFE014DA369Q36422305-ACC9BD3C-A0BA-4C6A-ACE6-A5370F3FDE79Q36573084-E846E452-FA62-4DF7-9106-C71442CE7589Q37155585-FFA0C422-5652-4636-A90A-7B3A33FBF615Q37411657-BD1BE374-4078-4CE4-8217-A5FD5C314A10Q38013072-1962F578-E8C7-44A9-A852-EC72D7AFC652Q38059788-E888AD94-14F6-49E5-92DF-292CDFB9D284Q39649613-D84280A3-8B91-404A-BC10-8B23303C704DQ40045765-6D0884C4-9820-4D32-8CC9-16EE9B75DA98Q47744408-C20D0F41-85C3-4F4A-B80D-E660C923A837Q50129848-3C3F9A6E-E2FE-4027-9ABC-8870A30FAF77Q55403242-7A3AC541-F721-4D8B-B67B-3000230C4044
P2860
Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Extending positron emission to ...... lity in follow-up of patients.
@en
Extending positron emission to ...... lity in follow-up of patients.
@nl
type
label
Extending positron emission to ...... lity in follow-up of patients.
@en
Extending positron emission to ...... lity in follow-up of patients.
@nl
prefLabel
Extending positron emission to ...... lity in follow-up of patients.
@en
Extending positron emission to ...... lity in follow-up of patients.
@nl
P2093
P1476
Extending positron emission to ...... lity in follow-up of patients.
@en
P2093
P304
P356
10.1200/JCO.2001.19.14.3397
P407
P577
2001-07-01T00:00:00Z